In addition to being implicated in the pathogenesis and transmission of prion diseases, increasing evidence demonstrates that PrPC contributes to tumorigenesis via multiple pathways by regulating tumor growth, differentiation, and resistance to conventional therapies [21,22,23,28,31,35,47] (Figure 1). Here, PRNP is linked to neoplasm.